We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take a look at where Pfizer Inc (NYSE:PFE) stands against other stocks that market experts are talking about these days.
Piper Sandler’s Chief Market Technician Craig Johnson said in a latest program on CNBC that despite the recent market volatility and “negative” headlines, he sees buying opportunities for long-term investors.
“The headlines out here are extremely negative all over the place and the sentiment toward this market is absolutely awful. Typically, you find these readings near sort of bear market lows, which is what you typically see. And if you also start to look at the VIX, it is elevated out here at this point in time. Now, technically we have broken some uptrends, we’ve closed below 50 and 200-day moving averages, but we’re getting to some pretty washed-out levels. I started looking at new highs, new lows, breadth indicators, and all these pieces. And we’re starting to get to levels where you look back and say, “Is this 1989? Is this a period of time that’s like the great financial crisis or the ’87 market crash?” And I think the answer to that is flat out no. So, we’re setting ourselves up for, I think, a potentially pretty good buying opportunity. All this negativity, and again, as Warren Buffett has said, you’ve got to be greedy when people are fearful. When people are greedy, and definitely a lot of fear out here, that seems to me to be a little bit misplaced on the charts.”
READ ALSO: 7 Best Stocks to Buy For Long-Term and 8 Cheap Jim Cramer Stocks to Invest In
For this article, we picked 10 stocks notable Wall Street analysts were discussing over the past few days. With each company we have mentioned the latest hedge fund sentiment. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Photo by Spencer Davis on Unsplash
Pfizer Inc (NYSE:PFE)
Number of Hedge Funds Investors: 92
Joshua Brown from Ritholtz Wealth Management recently talked about Pfizer Inc (NYSE:PFE) during a program on CNBC. Here is what he said about the stock that is down 7% over the past 12 months:
“This is like the worst stock on earth. It stopped going down, interestingly. It’s not going up like a lot of healthcare stocks did from the start of this year. So I missed out on that rotation by literally owning the worst healthcare stock in the world. But 18 times trailing P/E, 10 times trailing EV to EBITDA. They’ve had huge earnings challenges because they bet the ranch on COVID, and that ship has sailed. They haven’t replaced it yet with a robust enough pipeline for people to start taking their estimates higher. But that’s, I think, how I get bailed out of this thing. I’m flat. I don’t want anyone to feel bad. I have much worse stocks. But just the way that this company is being treated by investors right now, it’s like a ghost. But I think ultimately this is the type of stock where when it does turn, it’ll move too fast to catch it. And so that’s what I’m positioned for.”
Overall, PFE ranks 5th on our list of stocks that market experts are talking about these days. While we acknowledge the potential of PFE, our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. This article is originally published at Insider Monkey.
